You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
SBIR Phase II:Development of a Distributed Ledger System to Track Environmental Sustainability
SBC: MAP-COLLECTIVE, INC. Topic: ETThe broader/commercial impact of this Small Business Innovation Research (SBIR) Phase II project centers around its potential contribution to the coordination of climate change mitigation performance of governments, industry, and individuals towards a carbon negative future. The automated system for carbon tracking and visualization that this project is evolving could allow it to network many orga ...
SBIR Phase II 2023 National Science Foundation -
SBIR Phase II: A Blockchain Ecosystem for Encrypting Real World Data and Developing Artificial Intelligence to Optimize Pharmacy Prior Authorization
SBC: Red Oak Strategic, LLC Topic: DLThe broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase II project is to significantly reduce administrative inefficiency in pharmaceutical benefit management processing. The specific focus is on prior authorization processing, where payers and prescribers must reach a consensus on medical necessity. The project delivers a solution to optimize prescription a ...
SBIR Phase II 2023 National Science Foundation -
SBIR Phase II:HealthText: Providing digital healthcare navigation for underserved communities in the US
SBC: LISA FITZPATRICK & ASSOCIATES MD PC Topic: DHThe broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase II project aims to further develop HealthText, an artificial intelligence (AI) driven digital health information and navigation platform tailored to support the Medicaid population. The project's broader impact lies in its potential to address health disparities in under-resourced communities by providi ...
SBIR Phase II 2023 National Science Foundation -
Expansion and validation of novel mobile app for guiding home modifications for aging in place
SBC: HomesRenewed Ventures LLC Topic: RPROJECT SUMMARY In this Phase II SBIR, HomesRenewed Ventures, LLC (HRV Washington, DC) will build on our previous efforts to expand and validate an interactive mobile application (APP) for guiding home modifications (environmental interventions) critical to Aging in Place (AiP). Home modifications (HM) are associated with falls preventions, improved activities of daily living (ADLs), and emotional ...
SBIR Phase II 2023 Department of Health and Human ServicesNational Institutes of Health -
Stabilization of therapeutic microbes for inclusion in a liquid matrix for delivery to the intestines
SBC: Vitakey Inc. Topic: 300Project Summary/Abstract Enteral feeding (EF) is an essential medical procedure used to supply nutrients directly to the gastrointestinal (GI) tract of patients who are unable to eat independently. EF formula is often purchased as a ready-to-use liquid that contains carbohydrates, protein, fats, and micronutrients to ensure adequate nutritional benefit for the patient. The addition of therapeutic ...
SBIR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health -
A Vitamin K analog countermeasure for organophosphate poisoning
SBC: NEUROENE THERAPEUTICS INC Topic: NIAIDAbstract Neuroene Therapeutics has discovered a novel class of well-tolerated, brain-penetrating, non-sedating compounds that are small analogs of Vitamin K (VK) that mimic the form of VK needed for mitochondrial and neurological health. Our VK analogs are effective in several animal models of pharmacoresistant seizures and Parkinson's disease. Our lead antiseizure drug (ASD) candidate is fast-act ...
SBIR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health -
In vivo feasibility of a smart needle ablation treatment for liver cancer
SBC: CURRENT SURGICAL INC Topic: 102Project Summary A significant number (~30-50%) of liver cancers have no curative treatments due to their proximity to critical anatomy. Minimally invasive thermal ablation is a promising treatment for these untreatable solid tumors. If delivered precisely, ablations offer the treatment efficacy of traditional surgery with lower patient risk, clinician time, and overall cost. Existing ablation tech ...
SBIR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health -
The EdvoReader: Developing a Quantitative PCR and Colorimetry Instrument for Laboratory Skills Training
SBC: EDVOTEK INC Topic: 500Project Summary: The field of quantitative biology involves using mathematics, statistics, and modeling to analyze the results of biological experiments. Students at the high school and undergraduate levels can develop these skills through a comprehensive STEM (science, technology, engineering, and math) education. These analytical skills are crucial for success in many careers, including those in ...
SBIR Phase II 2023 Department of Health and Human ServicesNational Institutes of Health -
Hydrosat: Next Generation High-Resolution Daily Surface Temperature for Interconnected Earth Processes
SBC: HYDROSAT INC Topic: 94Temperature is the critical signal that allows monitoring of a myriad of Earth’s processes. From direct measurements of wildfire and urban heat to more complex relationships with drought, agriculture, aquaculture, and biodiversity, maintaining a steady pulse on Earth’s surface temperature enables us to mitigate for and adapt to the impacts of extreme events and increasingly variable water avai ...
SBIR Phase I 2023 Department of CommerceNational Oceanic and Atmospheric Administration -
Low SWaP, UxS-Mounted System for In-Situ Monitoring of Harmful Algal Blooms
SBC: HYDROSAT INC Topic: 92The brevetoxins (PbTx) produced by Karenia brevis cause harmful algal blooms (HAB) or "red tide" in seawater. Currently, the only available ways of detecting PbTx are laboratory tests such as enzyme-linked immunosorbent assays, which are expensive and slow, and require complex instrumentation and multiple processing steps. In previous work Intelligent Optical Systems (IOS) demonstrated a compact l ...
SBIR Phase I 2023 Department of CommerceNational Oceanic and Atmospheric Administration